Plasma membrane cholesterol: A critical determinant of cellular energetics and tubular resistance to attack

Kidney International

Volumn 58, Issue 1, 2000, Pages 193-205

  Zager, Richard A ^a,b   Johnson, Ali ^a   Anderson, Katie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Acquired cytoresistance; Adenosine triphosphate; Calvcolae; Cholesterol oxidase; Injury pathways; Rafts

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; CALCIUM IONOPHORE; CHOLESTEROL; CHOLESTEROL ESTERASE; CHOLESTEROL OXIDASE; IRON; LACTATE DEHYDROGENASE; OUABAIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL ENERGY; CELL FUNCTION; CELL MEMBRANE; CELL MEMBRANE RESISTANCE; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HOMEOSTASIS; KIDNEY TUBULE DAMAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0033916957     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00154.x     Document Type: Article

References (53)

1. 1. HONDA N, HISHIDA A, IKUMA K, YONEMURA K: Acquired resistance to acute renal failure. Kidney Int 31:1233-1238, 1987
2. 2. MCNIDER WB: The functional and pathologic response of the kidney in dogs subjected to a second subcutaneous injection of uranium nitrate. J Exp Med 49:411-431, 1929
3. 3. HAYES JM, BOONSHAFT B, MAHER JF, O'CONNELL JMB, SCHRIENER GE: Resistance to glycerol induced acute renal failure. Nephron 7:155-164, 1970
4. 4. ELLIOTT WE, HOUGHTON DC, GILBERT DN, BAINES-HUNTER J, BENNETT WM: Gentamicin nephrotoxicity. II. Definition of conditions necessary to induce acquired insensitivity. J Lab Clin Med 100:513-525, 1982
5. 5. LUFT F, YUM L, KLEIT S: The effect of concomitant mercuric chloride and gentamicin on kidney function and structure in the rat. J Lab Clin Med 89:622-631, 1977
6. 6. ZAGER RA, BALTES LA: Progressive renal insufficiency induces increasing protection against ischemic acute renal failure. J Lab Clin Med 103:511-523, 1984
7. 7. ZAGER RA, BALTES LA, SHARMA HM, JURKOWITZ MS: Responses of the ischemic acute renal failure kidney to additional ischemic events. Kidney Int 26:689-701, 1984
8. 8. IWATA M, HERRINGTON J, ZAGER RA: Protein synthesis inhibition induces cytoresistance in cultured human proximal tubular (HK-2) cells. Am J Physiol 268:F1154-F1163, 1995
9. 9. EMANI A, SCHWARTZ JH, BORKAN SC: Transient ischemia or heat stress induces a cytoprotective protein in rat kidney. Am J Physiol 265:F479-F485, 1991
10. 10. WAKUI H, KOMATSUDA A, MIURA AB: Heat-shock proteins in animal models for acute renal failure. Ren Fail 17:641-649, 1995
11. 11. NATH KA, BALLA G, VERCELLOTTI J, BALLA H, JACOB H, LEVITT M, ROSENBERG M: Induction of heme oxygenase is a rapid protective response in rhabdomyolysis in the rat. J Clin Invest 90:267-270, 1992
12. 12. VOGT BA, ALAM J, CROATT AJ, VERCELLOTTI GM, NATH KA: Acquired resistance to acute renal failure: Possible role of heme oxygenase and ferritin. Lab Invest 72:474-483, 1995
13. 13. PLATT JL, NATH KA: Heme oxygenase: Protective gene of Trojan horse? Nat Med 4:1364-1365, 1998
14. 14. AGARWAL A, BALLA J, ALAM J, NATH KA: Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48:1298-1307, 1995
15. 15. VOGT BA, SHANLEY TP, CROATT A, ALAM J, JOHNSON KJ, NATH KA: Glomerular inflammation induces resistance to tubular injury in the rat: A novel form of acquired heme oxygenase-dependent resistance to renal injury. J Clin Invest 98:2139-2145, 1996
16. 16. ICHIKAWA I, KIYAMA S, YOSHIOKA T: Renal antioxidant enzymes: Their regulation and function. Kidney Int 45:1-9, 1994
17. 2 and hydroxyl radical in cytoresistant proximal tubules. Kidney Int 52:942-952, 1997
18. 18. ZAGER RA: Heme protein induced tubular cytoresistance: Expression at the plasma membrane level. Kidney Int 47:1336-1345, 1995
19. 19. ZAGER RA, BURKHART KM, JOHNSON ACM, SACKS BM: Increased proximal tubular cholesterol content: Implications for cell injury and "acquired cytoresistance." Kidney Int 56:1788-1797, 1999
20. 20. COLEMAN PS, CHEN LC, SEPP-LORENZINO L: Cholesterol metabolism and tumor cell proliferation. Subcell Biochem 28:363-435, 1997
21. 21. COX AD, DER CJ: The ras/cholesterol connection: Implications for ras oncogenicity. Crit Rev Oncog 3:365-400, 1992
22. 22. LANGE Y, SWAISGOOD MH, RAMOS BV, STECK TL: Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. J Biol Chem 264:3786-3793, 1989
23. 23. LISCUM L, MUNN NJ: Intracellular cholesterol transport. Biochim Biophys Acta 1438:19-37, 1999
24. 24. FIELDING CJ, FIELDING PE: Intracellular cholesterol transport. J Lipid Res 38:1503-1521, 1997
25. 25. VAZQUEZ CM, ROVIRA N, RUIZ-GUTIERREZ V, PLANAS JM: Developmental changes in glucose transport, lipid composition and fluidity of jejunal BBM. Am J Physiol 272:R1086-R1093, 1997
26. 26. HARTEL S, DIEHL HA, OJEDA F: Methyl beta cyclodextrins and liposomes as water soluble carriers for cholesterol incorporation into membranes and its evaluation by a microenzymatic fluorescence assay and membrane fluidity sensitive dyes. Anal Biochem 258:277-284, 1998
27. +-dependent glucose transport. J Clin Invest 80:647-654, 1987
28. 28. ZAGER RA: Sphingomyelinase and membrane sphingomyelin content: Determinants of proximal tubule cell susceptibility to injury. J Am Soc Nephrol 11:894-902, 2000
29. 29. BROWN DA, LONDON E: Function of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111-136, 1998
30. 30. BROWN DA, LONDON E: Structure and origin of order lipid domains in biological membranes. J Membr Biol 165:103-114, 1998
31. 31. SIMONS K, IKONEN E: Functional rafts in cell membranes. Nature 387:569-572, 1997
32. 32. ANDERSON RGW: The caveolae membrane system. Annu Rev Biochem 67:199-225, 1998
33. 33. BROWN DA, LONDON E: Structure of detergent-resistant membrane domains: Does phase separation occur in biological membranes? Biochem Biophys Res Commun 240:1-7, 1997
34. 34. LOCHHEAD KM, KHARASCH ED, ZAGER RA: Spectrum and subcellular determinants of fluorinated anesthetic-mediated proximal tubular injury. Am J Pathol 150:2209-2221, 1997
35. 2: A potentially important determinant of adenine nucleotide levels during hypoxic-and reoxygenation injury. J Am Soc Nephrol 7:2327-2339, 1996
36. 36. ZAGER RA, SACKS BM, BURKHART KM, WILLIAMS AC: Plasma membrane phospholipid integrity and orientation during hypoxic and toxic proximal tubular cell attack. Kidney Int 56:104-117, 1999
37. 37. WEINBERG JM: The cell biology of ischemic renal injury. Kidney Int 39:476-500, 1991
38. 38. BONVENTRE JV: Mechanisms of ischemic acute renal failure. Kidney Int 43:1160-1178, 1993
39. 39. ZAGER RA: Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin Nephrol 17:3-14, 1997
40. 40. SOGABE K, ROESER NF, VENKATACHALAM MA, WEINBERG JM: Differential cytoprotection by glycine against oxidant damage to proximal tubule cells. Kidney Int 50:845-865, 1996
41. 41. WEINBERG JM, DAVIS JA, ABARZUA M, RAJAN T: Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. J Clin Invest 80:1446-1454, 1987
42. 42. WEINBERG JM, ROESER NF, DAVIS JA, VENKATACHALAM MA: Glycine protected hypoxic proximal tubules develop severely compromised energetic function. Kidney Int 52:140-151, 1997
43. 43. GOLDSTEIN JL, BROWN MS: Regulation of the mevalonate pathway. Nature 343:425-430, 1990
44. 44. LANGE Y, STREBEL F, STECK BL: Role of the plasma membrane in cholesterol esterification in rat hepatoma cells. J Biol Chem 258:13838-13843, 1993
45. 45. ZAGER RA: Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria. Kidney Int 49:741-751, 1996
46. 46. KONSTANTINOV AA, PESKIN AV, POPOVA E, YU KHOMUTOY GB, RUUGE EK: Superoxide generation by the respiratory chain of tumor mitochondria. Biochim Biophys Acta 894:1-10, 1987
47. 47. PALLER MS, HEDLUND BE: Role of iron in post-ischemic renal injury in the rat. Kidney Int 34:474-480, 1988
48. 48. ZAGER RA: Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress: Mechanistic and therapeutic implications. J Clin Invest 90:711-719, 1992
49. 49. UEDA N, GUIDET B, SHAH SV: Gentamicin-induced mobilization of iron from renal cortical mitochondria. Am J Physiol 265:F435-F439, 1993
50. 50. BALIGA R, ZHANG Z, BALIGA M, UEDA N, SHAH SV: In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53:394-401, 1998
51. 2+ ATPase, and inositol trisphosphate receptor. Proc Natl Acad Sci USA 92:1759-1763, 1995
52. 52. FUJIMOTO T: Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol 120:1147-1157, 1993
53. 53. SHAUL PW, SMART EJ, ROBINSON LJ, GERMAN Z, YUHANNA IS, YING Y, ANDERSON RG, MICHEL T: Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271:6518-6522, 1996